80% of skeletal metastases derive from breast, prostate, lung, kidney and thyroid tumours.
The most affected sites are the vertebral column, pelvis, skull, femur and the humerus. In 75% of cases bone metastases are responsible for a variety of complications called related skeletal events (SRE) which worsen the patient's quality of life.
Electrochemotherapy of bone metastases can slow or block the growth of metastatic cells and can control pain.
We would advise you to consult your doctor to find out if electrochemotherapy can help you.
The technology used for the treatment of bone metastases is Cliniporator® VITAE.
Please write to oncology@igeamedical.com to find out which hospital is closest to you.